Aplisens SA

WAR:APN Poland Scientific & Technical Instruments
Market Cap
$46.55 Million
zł193.55 Million PLN
Market Cap Rank
#27917 Global
#209 in Poland
Share Price
zł17.85
Change (1 day)
+0.00%
52-Week Range
zł16.80 - zł21.00
All Time High
zł24.77
Categories
Companies in Poland Scientific & Technical Instruments Technology AI & Machine Learning
About

Aplisens S.A. supplies industrial control and measurement equipment in Poland, European Union, CIS countries, the United States, Asia, and internationally. The company offers pressure, differential pressure, and level transducers; depth and level probes; electromagnetic flowmeters; measuring orifices; temperature sensors and transducers; valves and mounting accessories; meters, controllers, and d… Read more

Aplisens SA (APN) - Net Assets

Latest net assets as of September 2025: zł227.07 Million PLN

Based on the latest financial reports, Aplisens SA (APN) has net assets worth zł227.07 Million PLN as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł239.54 Million) and total liabilities (zł12.46 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets zł227.07 Million
% of Total Assets 94.8%
Annual Growth Rate 9.97%
5-Year Change 29.19%
10-Year Change 70.33%
Growth Volatility 9.8

Aplisens SA - Net Assets Trend (2008–2024)

This chart illustrates how Aplisens SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Aplisens SA (2008–2024)

The table below shows the annual net assets of Aplisens SA from 2008 to 2024.

Year Net Assets Change
2024-12-31 zł223.84 Million +4.32%
2023-12-31 zł214.57 Million +15.25%
2022-12-31 zł186.18 Million +3.01%
2021-12-31 zł180.74 Million +4.32%
2020-12-31 zł173.26 Million +5.89%
2019-12-31 zł163.62 Million +1.88%
2018-12-31 zł160.60 Million +6.60%
2017-12-31 zł150.66 Million +4.01%
2016-12-31 zł144.85 Million +10.22%
2015-12-31 zł131.42 Million +9.76%
2014-12-31 zł119.72 Million -0.42%
2013-12-31 zł120.24 Million +12.06%
2012-12-31 zł107.30 Million +13.61%
2011-12-31 zł94.45 Million +19.41%
2010-12-31 zł79.10 Million +13.63%
2009-12-31 zł69.61 Million +42.26%
2008-12-31 zł48.93 Million --

Equity Component Analysis

This analysis shows how different components contribute to Aplisens SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1714.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings zł195.01 Million 89.27%
Common Stock zł2.23 Million 1.02%
Other Comprehensive Income zł2.08 Million 0.95%
Other Components zł19.13 Million 8.76%
Total Equity zł218.44 Million 100.00%

Aplisens SA Competitors by Market Cap

The table below lists competitors of Aplisens SA ranked by their market capitalization.

Company Market Cap
IKTINOS HELLAS NA EO 010
F:F40
 		$11.51 Million
Harbor Bankshares Corporation
PINK:HRBK
 		$11.51 Million
US NeuroSurgical Holdings Inc
PINK:USNU
 		$11.51 Million
VOLT RESOURCES LTD
F:R8L
 		$11.51 Million
NANOBRICK Co. Ltd
KQ:286750
 		$11.51 Million
Hydrogen Freehold & Leasehold Real Estate Investment Trust
BK:HYDROGEN
 		$11.51 Million
Atlantis Yatirim Holding AS
IS:ATSYH
 		$11.50 Million
PT Salim Ivomas Pratama Tbk
STU:2IR
 		$11.50 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Aplisens SA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 209,743,000 to 218,442,000, a change of 8,699,000 (4.1%).
  • Net income of 20,743,000 contributed positively to equity growth.
  • Dividend payments of 11,150,000 reduced retained earnings.
  • Share repurchases of 7,984,000 reduced equity.
  • New share issuances of 2,619,000 increased equity.
  • Other comprehensive income increased equity by 808,000.
  • Other factors increased equity by 3,663,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income zł20.74 Million +9.5%
Dividends Paid zł11.15 Million -5.1%
Share Repurchases zł7.98 Million -3.65%
Share Issuances zł2.62 Million +1.2%
Other Comprehensive Income zł808.00K +0.37%
Other Changes zł3.66 Million +1.68%
Total Change zł- 4.15%

Book Value vs Market Value Analysis

This analysis compares Aplisens SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.90x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 3.62x to 0.90x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2008-12-31 zł4.93 zł17.85 x
2009-12-31 zł5.89 zł17.85 x
2010-12-31 zł6.72 zł17.85 x
2011-12-31 zł7.32 zł17.85 x
2012-12-31 zł8.22 zł17.85 x
2013-12-31 zł8.94 zł17.85 x
2014-12-31 zł8.85 zł17.85 x
2015-12-31 zł10.08 zł17.85 x
2016-12-31 zł10.89 zł17.85 x
2017-12-31 zł11.61 zł17.85 x
2018-12-31 zł12.71 zł17.85 x
2019-12-31 zł13.00 zł17.85 x
2020-12-31 zł14.41 zł17.85 x
2021-12-31 zł15.13 zł17.85 x
2022-12-31 zł16.44 zł17.85 x
2023-12-31 zł19.27 zł17.85 x
2024-12-31 zł19.91 zł17.85 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Aplisens SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.50%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 13.35%
  • • Asset Turnover: 0.66x
  • • Equity Multiplier: 1.08x
  • Recent ROE (9.50%) is below the historical average (11.45%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2008 17.59% 18.88% 0.77x 1.22x zł3.68 Million
2009 10.11% 15.51% 0.60x 1.08x zł76.70K
2010 12.36% 20.90% 0.57x 1.04x zł1.86 Million
2011 12.77% 17.33% 0.65x 1.13x zł2.61 Million
2012 13.79% 17.91% 0.67x 1.14x zł4.03 Million
2013 12.11% 18.06% 0.59x 1.14x zł2.52 Million
2014 10.61% 14.14% 0.68x 1.10x zł722.50K
2015 10.51% 15.52% 0.63x 1.07x zł665.40K
2016 9.84% 14.95% 0.61x 1.09x zł-233.50K
2017 13.20% 19.68% 0.62x 1.08x zł4.76 Million
2018 9.04% 13.55% 0.61x 1.10x zł-1.52 Million
2019 8.77% 11.90% 0.68x 1.09x zł-1.98 Million
2020 8.48% 13.38% 0.59x 1.07x zł-2.59 Million
2021 9.73% 14.17% 0.63x 1.09x zł-483.10K
2022 11.20% 13.83% 0.73x 1.11x zł2.19 Million
2023 15.07% 19.37% 0.70x 1.11x zł10.64 Million
2024 9.50% 13.35% 0.66x 1.08x zł-1.10 Million

Industry Comparison

This section compares Aplisens SA's net assets metrics with peer companies in the Scientific & Technical Instruments industry.

Industry Context

  • Industry: Scientific & Technical Instruments
  • Average net assets among peers: $57,082,914
  • Average return on equity (ROE) among peers: 1556.91%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Aplisens SA (APN) zł227.07 Million 17.59% 0.05x $11.51 Million
PZ Cormay SA (CRM) $50.00 Million -10.53% 0.79x $7.68 Million
Introl S.A. (INL) $122.53 Million 13.49% 1.12x $9.15 Million
Sonel S.A. (SON) $60.17 Million 7720.53% 0.14x $17.21 Million
Satis Group S.A. (STS) $49.71 Million 31.64% 1.56x $427.12K
Neptis (YAN) $3.01 Million 29.42% 2.30x $10.79 Million